Lecia V. Sequist, MD, MPH

Dr. Lecia Sequist is originally from Michigan and studied chemistry at Cornell University. She received her MD from Harvard Medical School and trained in internal medicine at the Brigham and Women’s Hospital and in hematology/oncology at the Dana-Farber Cancer Institute, where she also received an MPH from the Harvard School of Public Health. She joined the faculty at the Massachusetts General Hospital Cancer Center in 2005 and is currently the Landry Family Professor of Medicine at Harvard Medical School, the Director of the Center for Innovation in Early Cancer Detection at Massachusetts General Hospital, and the leader of the Cancer Risk, Prevention and Early Detection Program at the joint Dana-Farber/Harvard Cancer Center. She sits on the Board of Directors for the International Association of Lung Cancer, the Thoracic Malignancy Steering Committee for the NCI, and the Scientific Board of Directors for LUNGevity Foundation. Dr. Sequist’s research focuses on studying targeted therapeutics for lung cancer and novel technologies and approaches to lung cancer screening. She is passionate about Health Equity. In her free time, she likes to spend time with her husband, two sons, and two dogs, read and paint.